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![Critical regulatory regions in the *PITX1* promoter govern its expression in chondrocytes.\
Human C28/I2 chondrocyte cells were cotransfected with either the empty pGL4 plasmid (luciferase reporter plasmid) or the pGL4 plasmids containing different regions of the *PITX1* promoter combined with either the empty pBabe plasmid or pBabe plasmids expressing ER (estrogen receptor) fused to E2F1, E2F2, or E2F3 and induced with 4OH-tamoxifen (OHT) for 24 h. **(A)** The -3895/+61 *PITX1* gene region contains regulatory elements capable of producing a luciferase signal that is not affected by OHT treatment. **(B)** Overexpression of E2F1, E2F2, and E2F3 produces a significant increase in the luciferase activity under the control of the -3895/+61 *PITX1* gene region. **(C)** The proximal sequence of the *PITX1* promoter contains several E2F1 binding sites, as predicted by MatInspector 8.0 software (Genomatix Software Suite). **(D)** Overexpression of E2F1 has variable effects on luciferase activity depending on the length of the transfected promoter region (-3895/+61; -374/+61; -279/+61; -214/+61; -169/+61; -84/+61). Except for the -84/+61 *PITX1* gene region, all the other constructs are significantly activated by E2F1. **(Fig 1A, 1B and 1D)** Data represents mean and standard deviation of 3 independent experiments. Asterisks represent a significant increase in luciferase activity (Two-way ANOVA; Bonferroni *post hoc*: \*p \< 0.0001) compared with control cells.](pone.0167530.g001){#pone.0167530.g001}
